Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InspireMD (NSPR) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $2.6 million.

  • InspireMD's Other Operating Expenses rose 67168.67% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 26231.66%. This contributed to the annual value of $1.4 million for FY2024, which is 35381.88% up from last year.
  • According to the latest figures from Q3 2025, InspireMD's Other Operating Expenses is $2.6 million, which was up 67168.67% from $2.5 million recorded in Q2 2025.
  • InspireMD's Other Operating Expenses' 5-year high stood at $2.6 million during Q3 2025, with a 5-year trough of $92000.0 in Q1 2024.
  • For the 5-year period, InspireMD's Other Operating Expenses averaged around $961421.1, with its median value being $844000.0 (2024).
  • As far as peak fluctuations go, InspireMD's Other Operating Expenses tumbled by 8832.49% in 2024, and later skyrocketed by 127173.91% in 2025.
  • Over the past 5 years, InspireMD's Other Operating Expenses (Quarter) stood at $761000.0 in 2021, then skyrocketed by 42.84% to $1.1 million in 2022, then grew by 20.42% to $1.3 million in 2023, then crashed by 35.52% to $844000.0 in 2024, then skyrocketed by 203.55% to $2.6 million in 2025.
  • Its Other Operating Expenses was $2.6 million in Q3 2025, compared to $2.5 million in Q2 2025 and $1.3 million in Q1 2025.